推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-34243363

chinasupport@letpub.com

登录 注册 新注册优惠

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 J CANCER RES CL最新评论:11-2大修 编辑和审稿人很专业,提出了很多详细的意见,没有很刁钻,其中一个审稿人表示出认可,修回继续更新。。。 (2024-11-06)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY期刊基本信息Hello,您是该期刊的第169507位访客


基本信息 登录收藏
期刊名字JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGYJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

J CANCER RES CLIN
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
6.8
75人评分
我要评分

声誉
7.3

影响力
5.8

速度
9.0

期刊ISSN0171-5216
微信扫码收藏此期刊
E-ISSN1432-1335
2023-2024最新影响因子
(数据来源于搜索引擎)
2.7 点击查看影响因子趋势图
实时影响因子 截止2024年10月29日:2.111
2023-2024自引率3.70%点击查看自引率趋势图
五年影响因子3.1
JCI期刊引文指标 0.62
h-index 87
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
4.001.0230.953
学科分区排名百分位
大类:Medicine
小类:Oncology
Q3207 / 404
大类:Medicine
小类:Cancer Research
Q3154 / 230

期刊简介
The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers, also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses.

The following fields are covered: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology.
期刊官方网站https://www.springer.com/432
期刊投稿网址https://www.editorialmanager.com/jocr/
作者指南网址https://www.springer.com/432/submission-guidelines
期刊语言要求Language
Presenting your work in a well-structured manuscript and in well-written English gives it its best chance for editors and reviewers to understand it and evaluate it fairly. Many researchers find that getting some independent support helps them present their results in the best possible light.

经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY的语言要求,还能让JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY编辑和审稿人得到更好的审稿体验,让稿件最大限度地被JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢(1篇)
提交文稿
是否OA开放访问No
通讯方式SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013
出版商Springer Berlin Heidelberg
涉及的研究方向医学-肿瘤学
出版国家或地区GERMANY
出版语言English
出版周期Monthly
出版年份1904
年文章数 969点击查看年文章数趋势图
Gold OA文章占比35.02%
研究类文章占比:
文章 ÷(文章 + 综述)
89.06%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:3区

按JIF指标学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ3163/322
按JCI指标学科分区收录子集JCI分区JCI排名JCI百分位
学科:ONCOLOGYSCIEQ3172/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 1区3区2区
ONCOLOGY
肿瘤学
2区3区4区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区3区1区
ONCOLOGY
肿瘤学
3区3区3区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区3区4区
ONCOLOGY
肿瘤学
1区3区3区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0171-5216%5BISSN%5D
平均审稿速度网友分享经验:
平均1.0个月
平均录用比例网友分享经验:
约54.16%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    Nature Reviews Clinical Oncology12799.40
    NATURE REVIEWS CANCER396111.90
    ANNALS OF ONCOLOGY21063.90
    CANCER CELL29555.20
    JOURNAL OF CLINICAL ONCOLOGY49441.20
    LANCET ONCOLOGY27462.10
    CANCER RESEARCH41116.10
    SEMINARS IN CANCER BIOLOGY13426.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6718.20
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE671386
    BIOMATERIALS562968
    BIOMEDICINE & PHARMACOTHERAPY546646
    Frontiers in Pharmacology510641
    Journal of Materials Chemistry B499666
    Frontiers in Immunology486920
    COMPUTERS IN BIOLOGY AND MEDICINE467184
    JOURNAL OF ETHNOPHARMACOLOGY461389
    COLLOIDS AND SURFACES B-BIOINTERFACES436041
    Frontiers in Oncology432393
  •  

    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study

    Author: Lin, Xinqing; Deng, Haiyi; Li, Suyang; Xie, Xiaohong; Chen, Chao; Cai, Longqiu; Yang, Yilin; Qiu, Guihuan; Xie, Zhanhong; Qin, Yinyin; Liu, Ming; Zhou, Chengzhi
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 2, pp. 757-764. DOI: 10.1007/s00432-021-03903-0
        PubMed      DOI
    2.Surufatinib plus toripalimab in patients with advanced solid tumors: a single-arm, open-label, phase 1 trial

    Author: Cao, Yanshuo; Lu, Ming; Sun, Yu; Gong, Jifang; Li, Jie; Lu, Zhihao; Li, Jian; Zhang, Xiaotian; Li, Yan; Peng, Zhi; Zhou, Jun; Wang, Xicheng; Shen, Lin
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 2, pp. 779-789. DOI: 10.1007/s00432-021-03898-8
        PubMed      DOI
    3.Interim analysis of the efficiency and safety of neoadjuvant PD-1 inhibitor (sintilimab) combined with chemotherapy (nab-paclitaxel and carboplatin) in potentially resectable stage IIIA/IIIB non-small cell lung cancer: a single-arm, phase 2 trial

    Author: Sun, Chao; Liu, Yunpeng; Zhang, Peng; Wang, Xu; Xu, Yinghui; Lin, Xingyu; Ma, Xiaobo; Guo, Ye; Qiu, Shi; Shao, Guoguang; Yang, Zhiguang; Ma, Kewei
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 2, pp. 819-831. DOI: 10.1007/s00432-021-03896-w
        PubMed      DOI
    4.Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer

    Author: Poon, Darren M. C.; Yang, Bin; Geng, Hui; Wong, Oi Lei; Chiu, Sin Ting; Cheung, Kin Yin; Yu, Siu Ki; Chiu, George; Yuan, Jing
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 2, pp. 841-850. DOI: 10.1007/s00432-022-03950-1
        PubMed      DOI
    5.Comparison of clinical characteristics, treatment efficacy and survival in patients with newly diagnosed multiple myeloma with single- versus multi-site extramedullary invasion

    Author: Zhao, Yongfeng; Zhou, Fuling
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 3, pp. 995-1006. DOI: 10.1007/s00432-022-03948-9
        PubMed      DOI
    6.The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients

    Author: Wu, Guowu; Guo, Longhua; Gu, Yinfang; Huang, Tanxiao; Liu, Ming; Zou, Xiaofang; Yang, Bo; Huang, Ping; Wen, Chunling; Yi, Lilan; Liao, Wenting; Zhao, Dongdong; Zhu, Junlin; Zhang, Xiaoni; Liu, Yuanyuan; Yin, Yan; Chen, Shifu
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 3, pp. 1019-1028. DOI: 10.1007/s00432-022-03959-6
        PubMed      DOI
    7.Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis

    Author: Zhang, Shuwen; Chen, Jingjing; Zhang, Rui; Xu, Liqin; Wang, Yan; Yuan, Zaixin; Hou, Xiaohui; Feng, Jian
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 3, pp. 1063-1077. DOI: 10.1007/s00432-022-03970-x
        PubMed      DOI
    8.Optimizing the tumor shrinkage threshold for evaluating immunotherapy efficacy for advanced non-small-cell lung cancer

    Author: Du, Wei; Chen, Chen; Lin-feng Luo; Li-na He; Wang, Yixing; Zhang, Xuanye; Zhou, Yixin; Lin, Zuan; Hong, Shaodong
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 3, pp. 1103-1113. DOI: 10.1007/s00432-022-03978-3
        PubMed      DOI
    9.Correlation analysis between androgen receptor and the clinicopathological features and prognosis of mammary Paget's disease

    Author: Wu, Yang; Sun, Shanshan; Huang, Yuanxi; Xiao, Min; Zhao, Xuhai; Lu, Xiangshi; Xia, Bingshu; Qiao, Kun; Zhang, Shiyuan; Wu, Qiqi; Xiong, Jing; Cheng, Shaoqiang; Song, Yanni
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 3, pp. 1175-1184. DOI: 10.1007/s00432-022-03988-1
        PubMed      DOI
    10.Anti-angiogenic therapy for advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective multicenter study

    Author: Bao, Hejing; Ma, Ling Zhen; Zhao, Chengzhu; Yu, Mengge; Zhang, Baishen; Zhang, Juan; Peng, Guibao; Lin, Xiaotong; Fang, Yinhua; Bao, Hehong; Ma, Shudong
    Journal: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 2023; Vol. 149, Issue 3, pp. 1185-1193. DOI: 10.1007/s00432-022-03935-0
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    Computational Visual Media016.90
    Industrial and Organizational Psychology-Perspectives on Science and Practice07.70
    COMMUNICATIONS OF THE ACM18916.10
    MedComm06.70
    Journal of Econometrics1358.60
    CLINICAL NUCLEAR MEDICINE532.90
    Journal of International Financial Management & Accounting09.10
    BMJ Evidence-Based Medicine08.90
    ARCHIVOS DE BRONCONEUMOLOGIA413.50
    ARCHIVOS DE BRONCONEUMOLOGIA463.50
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

同领域作者分享投稿经验:共1948


    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室